FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the chemical-pharmaceutical industry and is a pharmaceutical tablet for oral administration comprising pelubiprofen and a controlled release polymer, wherein the tablet is prepared by tabletting a mixture comprising (i) a controlled release polymer and (ii) pelubiprofen, wherein the controlled release polymer is a water insoluble polymer selected from the group consisting of hydroxypropyl methylcellulose phthalate, acryl-EZETM, polyvinyl acetate, Kollidon SR and mixtures thereof.
EFFECT: invention provides an inhibition of the release of pelubiprofen in the gastrointestinal region to the maximum extent and maintenance of its release in the intestinal region.
1 cl, 4 dwg, 5 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID ORAL DOSAGE FORM PROLONGED RELEASING ACTIVE PHARMACEUTICAL SUBSTATION (APS) IN UPPER PART OF STOMACH | 2021 |
|
RU2786063C2 |
| METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
| SLOW-RELEASE MATRIX PREPARATION CONTAINING BASE AGENT OR ITS SALT AND METHOD FOR MAKING THEREOF | 2005 |
|
RU2390354C2 |
| TACROLIMUS FOR IMPROVED TREATMENT OF PATIENTS WITH GRAFTS | 2009 |
|
RU2574006C2 |
| DOSAGE FORMS CONTAINING TENELIGLIPTIN OXALATE SALTS AND SOLVATES THEREOF | 2018 |
|
RU2742418C1 |
| SYSTEMS OF MEDICATION DELIVERY, CONTAINING WEAK-BASE MEDICATIONS AND ORGANIC ACIDS | 2007 |
|
RU2428176C2 |
| PROLONGED-RELEASE PHARMACEUTICAL COMPOSITION OF ENTACAPONE OR ITS SALTS | 2009 |
|
RU2540465C2 |
| CISAPRID COMPOSITION OF PROLONGED RELEASE OF ACTIVE SUBSTANCE FOR ORAL ADMINISTRATION AND METHOD OF ITS PREPARING | 1995 |
|
RU2143890C1 |
| PHARMACEUTICAL COMPOSITION OF METFORMIN WITH PROLONGED RELEASE AND METHOD OF ITS OBTAINING | 2006 |
|
RU2433821C2 |
| PAROXETINE CHOLATE OR SALTS OF CHOLIC ACID DERIVATIVES AND COMPOSITION CONTAINING PAROXETINE AND CHOLIC ACID OR CHOLIC ACID DERIVATIVES | 2004 |
|
RU2337919C2 |
